Development of proneurogenic, neuroprotective small molecules.
Development of proneurogenic, neuroprotective small molecules.
复制标题
DOI:
10.1021/ja108211m
复制
发表时间:
2011-02-09
影响因子:
15
通讯作者:
Ready JM
中科院分区:
文献类型:
--
作者:
MacMillan KS;Naidoo J;Liang J;Melito L;Williams NS;Morlock L;Huntington PJ;Estill SJ;Longgood J;Becker GL;McKnight SL;Pieper AA;De Brabander JK;Ready JM
Degeneration of the hippocampus is associated with Alzheimer’s disease, and occurs very early in the progression of the disease. Current options for treating the cognitive symptoms associated with Alzheimer’s are inadequate, giving urgency to the search for novel therapeutic strategies. Pharmacologic agents that safely enhance hippocampal neurogenesis may provide new therapeutic approaches. We discovered the first synthetic molecule, named P7C3, which protects newborn neurons from apopotic cell death, and thus promotes neurogenesis in mice and rats in the subgranular zone of the hippocampal dentate gyrus, the site of normal neurogenesis in adult mammals. We describe the results of a medicinal chemistry campaign to optimize the potency, toxicity profile and stability of P7C3. Systematic variation of nearly every position of the lead compound revealed elements conducive towards increases in activity and regions subject to modification. We have discovered compounds that are orally available, non-toxic, stable in mice, rats and cell culture, and capable of penetrating the blood-brain barrier. The most potent compounds are active at nanomolar concentrations. Finally, we have identified derivatives that may facilitate mode-of-action studies through affinity chromatography or photocrosslinking.
登录
查看更多内容
影响因子:
82.9
作者:
Eriksson, PS;Perfilieva, E;Gage, FH
通讯作者:
Gage, FH
影响因子:
3.2
作者:
Alexander, MD;Burkart, MD;La Clair, JJ
通讯作者:
La Clair, JJ
影响因子:
1.8
作者:
Drexler, Dieter M.;Belcastro, James V.;Sanders, Mark
通讯作者:
Sanders, Mark
影响因子:
4
作者:
Imbimbo, Bruno P.;Giardino, Luciana;Calza, Laura
通讯作者:
Calza, Laura
影响因子:
4.9
作者:
Kan, T;Fukuyama, T
通讯作者:
Fukuyama, T